Bvf Inc Kymera Therapeutics, Inc. Transaction History
Bvf Inc
- $2.28 Billion
- Q1 2025
A detailed history of Bvf Inc transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 5,161,801 shares of KYMR stock, worth $152 Million. This represents 6.21% of its overall portfolio holdings.
Number of Shares
5,161,801
Previous 5,161,801
-0.0%
Holding current value
$152 Million
Previous $208 Million
31.97%
% of portfolio
6.21%
Previous 7.77%
Shares
7 transactions
Others Institutions Holding KYMR
# of Institutions
182Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$198 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$191 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$177 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$177 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$154 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.61B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...